levamisole, aminorex, and pulmonary arterial hypertension: a review

نویسندگان

steven b. karch consultant pathologist/toxicologist, berkeley, california, usa; consultant pathologist/toxicologist, berkeley, california, usa. tel: +1-5108490923

fabio vaiano department of health sciences, forensic toxicology division, university of florence, florence, italy

elisabetta bertol department of health sciences, forensic toxicology division, university of florence, florence, italy

چکیده

conclusions the results of the first human pharmacokinetic studies of aminorex were first characterized in 2013. the results suggest that while humans could produce aminorex from levamisole, they probably do not convert very much. even though cases of pah have been reported in cocaine users, the latest pharmacokinetic studies suggest that very little aminorex is actually produced from the ingested levamisole, probably not enough to cause pah. however, since both cocaine and aminorex can cause pah the situation remains unclear. the lack of a clear answer is partially the development of an insidious pulmonary hypertension, producing subtle and non-specific symptoms in its early stages. results approximately 70 percent of the u.s. cocaine supply and 40 percent of the european cocaine supply is contaminated with levamisole. aminorex has the same binding affinities for serotonin and other neurotransmitters as amphetamine. as serotonin is considered to be an important factor in the development of pah, the possibility of another epidemic of aminorex-induced pah, this time among cocaine abusers, seems real, and threatening. context an epidemic of aminorex-associated pulmonary arterial hypertension (pah), resulting in multiple fatalities, occurred in the 1970s ending only after the drug was removed from the market. in 2009, when it was found that horses de-wormed with the anthelmintic levamisole, metabolized that drug to aminorex, the same drug that caused the 1970s outbreak of pah. the discovery would not have been cause for concern except to horseracing enthusiasts, who feared horse doping. however, at about the same time the relationship between levamisole and aminorex was discovered, cocaine cartels began adulterating cocaine with levamisole. the rationale for adulterating cocaine with levamisole remains to be established. the purpose of this short review article is to discuss possible reasons for levamisole contamination, new discoveries about the human pharmacokinetics of aminorex, and the possible relationship between aminorex and pulmonary arterial hypertension in man. evidence acquisition medline contents, as well as estimates published by the u.s. drug enforcement agency (dea), us state department, and the european monitoring center for drugs and drug abuse (emcdda) were reviewed and relevant articles retrieved. there is uniform agreement among the various monitoring agencies analyzed.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

THE EFFECTS OF CAPTOPRIL ON PULMONARY AND SYS TEMIC ARTERIAL PRESSURES IN HIGHALTITUDE PULMONARY HYPERTENSION

The purpose of this investigation was to assess the effect of captopril on both systemic (P.a) and pulmonary arterial pressures (PPA) in patients with high-altitude pulmonary hypertension (HAPH). Seventeen patients (mean age 44±6.8 years) with HAPH and mild to moderate systemic arterial hypertension were included in the study. All patients underwent right heart catheterization with measurem...

متن کامل

Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed.

T he growing interest in pulmonary hypertension (PH) in many medical specialties including cardiology, rheumatology and respiratory medicine, is possibly due to the recent availability of specific drugs approved for a group of rare conditions defined as pulmonary arterial hypertension (PAH). The terms ‘‘pulmonary hypertension’’ and ‘‘pulmonary arterial hypertension’’ appear to be quite similar,...

متن کامل

Aminorex and the pulmonary circulation.

Aminorex (2-amino-5-phenyl-2-oxazoline) is an appetite-suppressing drug which was available in Switzerland from November 1965 to October 1968. In 1967 a sudden 20-fold increase in the incidence of primary pulmonary hypertension was observed in a Swiss medical clinic. It was noticed that a considerable number of these patients had taken aminorex to reduce weight. A similar increase in the incide...

متن کامل

A case of severe pulmonary hypertension associated with common arterial trunk and VSD in a 9 years old child

Background: Common arterial trunk (CAT) is a rare congenital heart disease, and often leads to the early development of pulmonary hypertension and disability. Among the critical structural heart defects, the frequency of CAT is 3%, which reflects the severe hemodynamic disturbances. The natural course of the disease is characterized by a high mortality rate up to 88% during the first year of li...

متن کامل

Novel Approaches to Treat Experimental Pulmonary Arterial Hypertension: A Review

BACKGROUND Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by an increase in pulmonary artery pressure leading to right ventricular (RV) hypertrophy, RV failure, and ultimately death. Current treatments can improve symptoms and reduce severity of the hemodynamic disorder but gradual deterioration in their condition often necessitates a lung transplant. METHOD...

متن کامل

A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy

Significant advances in the understanding of the pathophysiology of pulmonary arterial hypertension over the past two decades have led to the development of targeted therapies and improved patient outcomes. Currently, a broad armamentarium of pulmonary arterial hypertension-specific drugs exists to assist in the treatment of this complex disease state. In this manuscript, we provide a comprehen...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
razavi international journal of medicine

جلد ۳، شماره ۳، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023